Onderzoeker
Isabelle Vande Broek
- Trefwoorden:Geneeskunde
- Disciplines:Humane wetenschappen en de kunsten, Ingenieurswetenschappen en technologie, Natuurwetenschappen
Affiliaties
- Immunologie en Microbiologie (Departement)
Lid
Vanaf1 mrt 2010 → 30 sep 2010 - Hematologie (Onderzoeksgroep)
Lid
Vanaf1 okt 1999 → 31 okt 2010 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 1998 → 30 sep 2010
Publicaties
1 - 10 van 29
- Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study(2022)
Auteurs: Isabelle Vande Broek
- Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma(2015)
Auteurs: Isabelle Vande Broek, Françoise Majois, Jean-François Baurain, Sylvie Rottey, Andrée Rorive, Johan De Mey, Sylvia De Brakeleer
Pagina's: 6893-6899 - IMWG consensus on risk stratification in multiple myeloma(2014)
Auteurs: Wj Chng, A Dispenzieri, C.s. Chim, Benjamin Van Camp, Isabelle Vande Broek
Pagina's: 269-277 - Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients(2013)
Auteurs: Song Xu, Gaia Santini, Isabelle Vande Broek, Xavier Leleu, Benjamin Van Camp
- Epigenetic regulation of myeloma within its bone marrow microenvironment(2013)Volume: 1
Auteurs: Elke De Bruyne, Ken Maes, Sarah Deleu, E Van Valckenborgh, Eline Menu, Isabelle Vande Broek, Joanna Fraczek, Leo A van Grunsven, Vera Rogiers, Helena Jernberg-Wiklund, et al.
Pagina's: 255-282Aantal pagina's: 28 - Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo(2013)
Auteurs: Song Xu, Holly R. Evans, Gaia Santini, Isabelle Vande Broek, Xavier Leleu, Benjamin Van Camp, Peter I. Croucher
Pagina's: 699-709 - Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group(2013)
Auteurs: C. Fernández De Larrea, Robert Kyle, Brian Durie, Heinz Ludwig, S Usmani, Dh Vesole, Jésus F. San Miguel, Orthan Sezer, Pieter Sonneveld, Sk Kumar, et al.
Pagina's: 780-791 - Epigenetic modulation of myeloma within its bone marrow microenvironment(2013)Volume: 1
Auteurs: Sarah Deleu, E Van Valckenborgh, Isabelle Vande Broek, Joanna Fraczek, Helena Jernberg-Wiklund
Pagina's: 255-282Aantal pagina's: 28 - Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway(2012)
Auteurs: Song Xu, Holly R. Evans, Clive H. Buckle, Jinsong Hu, Dehui Xu, Isabelle Vande Broek, Xavier Leleu, Benjamin Van Camp, Peter I. Croucher
Pagina's: 2546-2549 - Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study(2012)
Auteurs: Sk Kumar, J. Lee, Jj Lahuerta, G Morgan, Pg Richardson, J Crowley, J Haessler, J Feather, A Hoering, Philippe Moreau, et al.
Pagina's: 149-157